$0.1934
-0.01-5.89%
At close: -
$0.1920
-0.00140-0.72%
After Hours: Jan 17, 7:59 PM EDT
Bionano Genomics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Bionano Genomics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-0.52 | $-0.21 | -147.6 % |
Q2 | 2024-08-07 | $-0.24 | $-0.42 | 42.9 % |
Q1 | 2024-05-08 | $-0.60 | $-0.64 | 6.25 % |
Q4 | 2024-03-05 | $-0.96 | $-0.87 | -10.3 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $6.07M | $7.85M | -22.6 % |
Q2 | 2024-08-07 | $7.77M | $8.00M | -2.86 % |
Q1 | 2024-05-08 | $8.77M | $8.49M | 3.29 % |
Q4 | 2024-03-05 | $10.72M | $10.58M | 1.33 % |
Bionano Genomics (BNGO) is scheduled to report earnings on March 4, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-0.52, which missed the estimate of $-0.21.
The Actual Revenue was $6.1M, which missed the estimate of $7.8M.
Browse earnings estimates, EPS, and revenue on all stocks.